The FGFR1 gene on the 8p11–12 chromosomal region is mutated in around 15% of breast cancer, more specifically in 27% of HER2-positive patients, in 23% of ER-positive patients and in 7% of TNBC patients [3,104,178]. This evidence concerns the gene FGFR1 and breast carcinoma.